.Attribute Medication, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medicine conjugate (ADC) tisotumab vedotin resulted in enhanced progression-free and also overall survival, triggering FDA commendation and also a brand-new therapy choice for individuals.